Arimidex vs Aromasin: Complete AI Guide for Steroid Cycles (2026)

Aromatase inhibitors (AIs) are not optional accessories to anabolic steroid cycles — for users running aromatising compounds, they are an essential component of a properly managed protocol. Arimidex (anastrozole) and Aromasin (exemestane) are the two most widely used AIs in performance enhancement. Understanding their differences, how to dose them correctly, and critically, the risk of over-suppressing oestrogen, is fundamental to running effective and safe cycles.

What Are Aromatase Inhibitors?

Aromatase inhibitors block the enzyme aromatase (also called CYP19A1), which converts androgens (particularly testosterone and androstenedione) into oestrogens (primarily oestradiol). When supraphysiological doses of aromatising steroids like testosterone are used, oestradiol levels rise substantially, causing oestrogen-related side effects. AIs prevent or reduce this conversion.

Arimidex (Anastrozole) vs Aromasin (Exemestane): The Critical Difference

Property	Arimidex (Anastrozole)	Aromasin (Exemestane)
Mechanism	Competitive, reversible inhibitor	Irreversible (steroidal) — suicide inhibitor
Reversibility	Reversible — oestrogen returns quickly when stopped	Irreversible — new aromatase enzyme must be synthesised
Oestrogen suppression potency	Up to 80% reduction at 1 mg/day	Up to 85–95% reduction at 25 mg/day
Effect on lipids	Slightly negative (HDL reduction)	Neutral to slightly positive (mild anabolic steroid structure)
Rebound oestrogen on cessation	Yes — oestrogen rebounds when stopped (competitive inhibitor)	No significant rebound (irreversible — new enzyme synthesised gradually)
Tablet strength available	0.5 mg, 1 mg	12.5 mg, 25 mg
Use during PCT	Not recommended (oestrogen rebound suppresses HPG recovery)	Acceptable; less rebound concern

Arimidex (Anastrozole): How to Use It

Anastrozole is the most widely used AI in performance enhancement. Key dosing principles:

• Starting dose: 0.5 mg every other day (EOD) is the standard starting point for a 400–500 mg/week testosterone cycle. Adjust based on bloodwork.
• Higher testosterone doses (600+ mg/week): May require 0.5–1 mg/day
• Target oestradiol: 20–40 pg/mL (70–150 pmol/L) — physiological mid-range for adult men. Do NOT aim to crash oestrogen to zero.
• When to take it: Anastrozole has a half-life of approximately 50 hours. EOD dosing maintains reasonably stable blood levels. Some users prefer daily dosing at 0.25–0.5 mg.
• Avoid during PCT: When you stop the anabolic steroid and begin PCT with Nolvadex, stop anastrozole simultaneously. As a competitive inhibitor, anastrozole suppresses oestrogen acutely — discontinuing it allows oestrogen to rebound rapidly, which actually helps stimulate LH and FSH recovery. Continuing it during PCT blunts this recovery.

Browse available Arimidex products.

Aromasin (Exemestane): How to Use It

Exemestane is a steroidal AI that irreversibly binds and deactivates aromatase enzymes. Key properties:

• Standard dose: 12.5–25 mg EOD for most testosterone cycles
• Onset: Slower than anastrozole due to its irreversible mechanism — takes longer to reach maximum suppression, but effects last longer
• Advantage over Arimidex: No oestrogen rebound on cessation; slight anabolic activity (steroidal structure); neutral-to-positive lipid effects
• PCT use: Exemestane can be continued into early PCT without the rebound concern associated with anastrozole
• Limitation: Higher cost than anastrozole; less fine-grained dosing control due to tablet sizes

The Most Important Principle: Do Not Crash Oestrogen

The most common mistake with AI use is over-suppression of oestrogen. Men require physiological oestrogen (target 20–40 pg/mL) for:

• Bone health: Oestrogen is the primary mediator of bone mineral density in men, not testosterone directly
• Joint lubrication: Low oestrogen causes joint dryness and pain, particularly in knees and elbows
• Cardiovascular health: Oestrogen plays a protective role in endothelial function and lipid management
• Mood and libido: Very low oestrogen causes depression, emotional flatness, and paradoxically reduced libido despite high androgen levels
• Cognitive function: Oestrogen plays a role in memory consolidation and cognitive performance

Symptoms of low oestrogen on-cycle: joint pain, fatigue, flat mood, loss of libido despite high testosterone, dry skin. If these appear, reduce or eliminate AI use and recheck bloodwork. For full protocols, see our harm reduction guide.

Blood Monitoring: The Only Way to Get AI Dosing Right

AI dosing based on fixed protocols without bloodwork is always a compromise. Individual aromatisation rates vary by up to 5–10 fold between users. The correct approach:

1. Baseline oestradiol blood test before starting the cycle
2. On-cycle oestradiol test at week 4–6 to assess conversion rate
3. Adjust AI dose to achieve target oestradiol of 20–40 pg/mL
4. Recheck at week 8–10 after dose adjustment

Arimidex in TRT

Anastrozole is frequently prescribed alongside TRT (testosterone replacement therapy) when oestradiol rises above the normal reference range. However, there is growing evidence that the benefits of AI use in TRT are less clear than previously assumed for most men — many TRT patients tolerate oestradiol at the upper end of the normal range without negative symptoms. Over-aggressive AI use in TRT leads to the low-oestrogen symptom profile described above. See our UK TRT complete guide for full context.

Frequently Asked Questions

Which AI is better: Arimidex or Aromasin?

Both are effective. Aromasin's irreversible mechanism, no-rebound profile, and neutral-to-positive lipid effects make it theoretically preferable for longer cycles. Arimidex's reversibility allows more rapid dose adjustment in response to bloodwork — if you over-suppress oestrogen with anastrozole, reducing the dose rapidly corrects it. With exemestane, you must wait for new aromatase to be synthesised. In practice, both work well when dosed correctly based on bloodwork.

Do you need an AI on every cycle?

Not necessarily. Cycles using non-aromatising compounds (Anavar, Winstrol, Masteron, Primobolan) do not require an AI. At very low testosterone doses (TRT-range 100–150 mg/week), many users do not require an AI. Whether an AI is needed should be determined by oestradiol bloodwork, not assumed from the protocol design.

Can you use Nolvadex instead of an AI?

Nolvadex (tamoxifen) is a SERM — it blocks oestrogen receptors rather than reducing oestrogen production. It can manage gynaecomastia symptoms by blocking breast tissue receptors, but it does not reduce oestrogen levels. High oestrogen with Nolvadex blocking will still cause water retention, blood pressure issues, and mood effects. AIs are the correct first-line approach for oestrogen management on-cycle; Nolvadex is valuable primarily in PCT and for gynecomastia prevention in specific circumstances. See our PCT guide for Nolvadex protocols.